ArticleFrontiers in oncology2024

Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy.

Yi Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.